References
- Guan WJ, Ni ZY, Hu Y, Liang WH, OU CQ, HE JX, LIU L, SHAN H, LEI CL,
HUI DSC, DU B, LI LJ, ZENG G, YUEN KY, CHEN R.C, TANG CL, WANG T, CHEN
PY, XIANG J., LI S. Y., WANG J. L., LIANG Z. J., PENG Y. X., WEI L.,
LIU Y., HU Y. H., PENG P., WANG J. M., LIU J. Y., CHEN Z., LI G.,
ZHENG Z. J., QIU S. Q., LUO J., YE C. J., ZHU S. Y., ZHONG N. S. &
CHINA MEDICAL TREATMENT EXPERT GROUP FOR C. 2020. China Medical
Treatment Expert Group for Covid-19. Clinical characteristics of
coronavirus disease 2019 in China. N Engl J Med 2020; NEJMoa2002032.
https://doi.org/10.1056/ NEJMoa2002032
- Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143
pediatric patients with 2019 coronavirus disease in China. Pediatrics
2020; published online March 16. DOI:10.1542/peds.2020-0702
- https://www.care.gov.eg/EgyptCare/Index.aspx (accessed on 17/6/2020))
- Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, Zhang Y, Zhang H, Jia R, Liu
P, Wang X, Ge Y, Xia A, Tian H, Chang H, Wang C, Li J, Wang J, and
Zeng M. A Case Series of children with 2019 novel coronavirus
infection: clinical and epidemiological features Clin Infect Dis. 2020
Feb 28 : ciaa198. doi: 10.1093/cid/ciaa198
- Dong Y, Mo X, Hu Y, Xin Qi, Fan Jiang, Zhongyi Jiang and Shilu Tong.
Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020
Mar. DOI: 10.1542/peds.2020-0702.
- Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A.
Characteristics and outcomes of coronavirus infection in children: the
role of viral factors and an immunocompromised state. J Pediatric
Infect Dis Soc. 2019;8(1):21-28.
- Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for cancer
patients. Lancet Oncol 2020; published online March 3. https://
doi:10·1016/S1470–2045(20)30150–9)
- Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet
Oncol 2020; published online March 3. https://doi.
org/10•1016/S1470–2045(20)30149–2
- Kotecha SR. Challenges posed by COVID-19 to children with cancer. The
lancet oncology 2020; 21(5):e235
- WHO. WHO director-general’s statement on IHR Emergency Committee on
Novel Coronavirus (2019-nCoV). Available at:
https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov).
Accessed March 3, 2020
- Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection
in children. N Engl J Med. 2020;382:1663-1665.
- Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D. How is
immunosuppressive status affecting children and adults in SARS-CoV-2
infection? A systematic review. J Infect . 2020;81(1):e61-e66.
- Sieni E, Pegoraro F, Casini T, et al. Favourable outcome of
coronavirus disease 2019 in a 1-year-old girl with acute myeloid
leukaemia and severe treatment-induced immunosuppression. Br J
Haematol . 2020;189(6):e222-e224. doi:10.1111/bjh.16781
- Abdulamir AS, Hafidh RR. The Possible Immunological Pathways for the
Variable Immunopathogenesis of COVID—19 Infections among Healthy
Adults, Elderly and Children. Electron J Gen Med. 2020;17(4).
- Ding YY, Ramakrishna S, Long AH, et al. Delayed cancer diagnoses and
high mortality in children during the COVID-19 pandemic [published
online ahead of print, 2020 Jun 26]. Pediatr Blood Cancer .
2020;e28427. doi:10.1002/pbc.28427
- Madariaga A, McMullen M, Sheikh S, et al. COVID-19 testing in cancer
patients: Does one size fit all? [published online ahead of print,
2020 Jul 2]. Clin Cancer Res . 2020; clincanres.2224.2020.
- Bose S, Adapa S, Aeddula NR, et al. Medical Management of COVID-19:
Evidence and Experience. J Clin Med Res . 2020;12(6):329-343.
- Athale U, Moghrabi A, Nayiager T, Delva YL, Thabane L, Chan AK. von
Willebrand factor and thrombin activation in children with newly
diagnosed acute lymphoblastic leukemia: an impact of peripheral
blasts. Pediatr Blood Cancer . 2010;54(7):963-969.
- Middleton EA, He XY, Denorme F, et al. Neutrophil Extracellular Traps
(NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory
Distress Syndrome [published online ahead of print, 2020 Jun
29]. Blood . 2020;blood.2020007008.
doi:10.1182/blood.2020007008
- Schorling RM, Pfrepper C, Golombek T, et al. Evaluation of Biomarkers
for the Prediction of Venous Thromboembolism in Ambulatory Cancer
Patients [published online ahead of print, 2020 Jun 24]. Oncol Res
Treat. 2020;1-10.
- Aryal MR, Gosain R, Donato A, et al. Venous Thromboembolism in
COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening,
and Treatment. Curr Cardiol Rep . 2020;22(7):52.
- Feng X, Li S, Sun Q, et al. Immune-Inflammatory Parameters in COVID-19
Cases: A Systematic Review and Meta-Analysis. Front Med
(Lausanne) . 2020; 7:301.
- Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and
treatment recommendations for pediatric respiratory infection caused
by the 2019 novel coronavirus. World J Pediatr. 2020.
Figure Legend